Clinical trials are key to the advancement of bariatric surgery technique and technology to treat morbid obesity. Clinical trials are conducted throughout the nation and generally evaluate whether surgery is appropriate for patients who currently do not qualify under current guidelines. Following are clinical trial resources for patients in New Jersey and across the US.
Bariatric Surgery for Low BMI Patients (Local, New Jersey)
Principal Investigators include: Drs. Muhammad Feteiha & James Lopes
This prospective trial is being conducted by Atlantic Health affiliated surgeons including two of our very own. We are seeking to establish the effectiveness of bariatric surgery on patients with a BMI of 30-34.9 that have certain obesity related conditions or comorbidities. Currently this subset of obese patients does not qualify for surgery under FDA guidelines, but there is reason to believe that they could benefit greatly from access to bariatric surgery. Patients with a BMI of up 35-40 with no comorbid conditions may also be considered for the trial. Qualifying comorbidities may include:
- Type-2 diabetes
- High blood pressure
- High cholesterol
- Sleep apnea
- Coronary artery disease
- GERD (chronic acid reflux)
- Polycystic ovarian syndrome
The procedures being performed on qualified patients, 18 years or older, will include gastric sleeve and gastric bypass. Patients will be evaluated by one of our physicians and will be followed at predefined intervals after surgery to determine improvements in obesity related conditions as well as overall weight loss.
For inclusion/exclusion criteria, costs and fees, please contact Atlantic Health at 908-522-5794
Other Clinical Trials
There are hundreds of ongoing clinical trials evaluating new and experimental treatments of obesity at any given time. Patients may search clinical trials at the US National Institutes of Health database here:
Use the filter to narrow your search to the state in which you live or to expand the search worldwide. Remember to consult your medical team before embarking on any new treatments – as part of a clinical trial or otherwise. Your safety is paramount.